Point72 Hong Kong’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,218
Closed -$193K 493
2024
Q4
$193K Buy
+2,218
New +$203K 0.01% 284
2024
Q3
Sell
-3,339
Closed -$360K 477
2024
Q2
$360K Buy
+3,339
New +$334K 0.02% 270
2022
Q4
Sell
-5,280
Closed -$348K 284
2022
Q3
$348K Buy
5,280
+5,174
+4,881% +$332K 0.01% 885
2022
Q2
$5K Sell
106
-3,207
-97% -$188K ﹤0.01% 1726
2022
Q1
$212K Buy
+3,313
New +$238K 0.01% 949
2021
Q4
Sell
-786
Closed -$81K 1919
2021
Q3
$81K Buy
+786
New +$73.2K ﹤0.01% 1400
2020
Q4
Sell
-506
Closed -$47K 1733
2020
Q3
$47K Buy
506
+435
+613% +$33.5K 0.01% 688
2020
Q2
$6K Sell
71
-352
-83% -$23.8K ﹤0.01% 1022
2020
Q1
$25K Buy
+423
New +$27.2K 0.01% 493
2019
Q4
Sell
-1,384
Closed -$102K 1166
2019
Q3
$102K Buy
+1,384
New +$120K 0.03% 449
2018
Q4
Sell
-436
Closed -$34K 903
2018
Q3
$34K Buy
+436
New +$30.3K 0.01% 522
2018
Q1
Sell
-1
Closed 907
2017
Q4
$0 Sell
1
-366
-100% -$25.8K ﹤0.01% 857
2017
Q3
$26K Buy
+367
New +$19.6K 0.02% 348
2017
Q2
Sell
-1,886
Closed -$75K 822
2017
Q1
$75K Buy
+1,886
New +$67.5K 0.1% 161

Other funds holding BPMC

Point72 Hong Kong's BPMC Position: Q1 2025 in Review

Point72 Hong Kong sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 2,218 shares — an estimated $193K sold.

Point72 Hong Kong first reported a position in BPMC in Q1 2017 and held it in 14 quarters. The position peaked at $360K in Q2 2024. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Point72 Hong Kong reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 2,218 Blueprint Medicines shares in Q1 2025, an estimated $193K.
  • Point72 Hong Kong first reported a position in Blueprint Medicines in Q1 2017 and held it in 14 quarters.
  • Point72 Hong Kong's Blueprint Medicines position peaked at $360K in Q2 2024.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.